Anaesthetic Agent Consumption Now Available on the Prima 465

Anaesthetic agent consumption is now available on Penlon Prima 465 anaesthetic machines fitted with anaesthetic gas monitoring modules. The new anaesthetic agent consumption calculation displays the amount of agent consumed in mL on a case-by-case basis and is available to view at any point during, and at the end of the case.

Sevoflurane, Isoflurane, Desflurane, Enflurane and Halothane use can be displayed, for billing purposes and to help better understand agent consumption throughout surgery, particularly during low flow anaesthesia.

The Prima 465 anaesthetic machine is the ideal solution for today’s busy operating room, with an electronic gas mixer, 12.1” touchscreen and multiple anaesthetic gas monitoring options.

Craig Thompson, Penlon’s Product Manager, said:
 

“We are delighted to be able to offer this new feature on the Prima 465. Our customers told us they wanted it, and we've been able to deliver it quickly thanks to the hard work of our engineering team. We look forward to implementing more enhancements to our range of anaesthetic range soon.”

The Prima 465 anaesthetic machine and other products from Penlon’s portfolio will be on display at FIME (Miami, USA), Africa Health (Johannesburg, S Africa), Medica (Düsseldorf, Germany), Arab Health (Dubai, UAE) and forthcoming events during 2022.

About Penlon

Penlon is a world-class British medical device company established in Oxford in 1943. Penlon develops, manufactures and exports anaesthesia and other medical products to over ninety countries worldwide. Penlon has been designing and manufacturing anaesthesia equipment in the UK for nearly eighty years.

In 2020 Penlon responded to the UK Government’s call to arms by producing 11,683 ventilators in just three months in the fight against COVID-19.